Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220007797 220020442 1.74 null Curative (C) 2015-10-13 2015-10-13 AML18 PILOT TRIAL N N 220033159 PILOT TRIAL
220007798 220020442 1.68 56.5 Not known (9) 2014-03-23 2014-03-23 Idarubicin+Tretinoin Spanish Crse4 N null 220033159 IDARUBICIN + TRETINOIN
220007799 220003096 1.82 81.8 null null 2013-09-05 AML16 Low Dose Cytarabine Y N 220033174 AML16 TRIAL
220007800 220011726 1.6 null Curative (C) 2015-06-18 2015-06-18 CARBOPLATIN + PACLITAXEL 2 N 220033175 CARBOPLATIN + PACLITAXEL
220007801 220011726 null null Palliative (P) 2017-11-26 2017-12-09 Cisplatin + Gemcitabine (D 1 & 8) N null 220033175 CISPLATIN + GEMCITABINE
220007802 220018935 1.7 95.5 Palliative (P) 2016-04-21 2016-05-02 GemCarbo Days 1+8 2 N 220033179 GEMCARBO
220007803 220018935 1.86 null Palliative (P) 2013-08-16 2013-08-22 CARBOPLATIN + PACLITAXEL N N 220033179 CARBOPLATIN + PACLITAXEL
220007804 220003097 1.61 106 Disease modification (D) null 2014-12-26 AML18 PILOT TRIAL 1 N 220033188 PILOT TRIAL
220007805 220003097 null 77.6 Curative (C) 2014-02-13 2014-02-16 Carboplatin + Paclitaxel (weekly) null N 220033188 CARBOPLATIN + PACLITAXEL
220007806 220003097 1.5 47.2 Curative (C) 2015-03-23 2015-03-24 IDARUBICIN + TRETINOIN 02 N 220033188 IDARUBICIN + TRETINOIN
220007808 220003099 null 0 Disease modification (D) 2018-11-06 2018-11-09 Dasatinib 2 N 220033199 DASATINIB
220007809 220011728 1.64 76.9 Curative (C) 2016-05-20 2016-05-26 Carboplatin + Paclitaxel (3 weekly) 02 null 220033201 CARBOPLATIN + PACLITAXEL
220007810 220011728 1.94 84.9 Curative (C) 2013-08-06 2013-07-10 Carboplatin + Paclitaxel (3 weekly) N N 220033201 CARBOPLATIN + PACLITAXEL
220007811 220018936 1.7 88 null 2015-10-03 2015-10-06 GEMCARBO 02 N 220033204 GEMCARBO
220007812 220018936 1.73 69.1 null 2015-08-21 2015-08-21 CISPLATIN + GEMCITABINE 02 Y 220033204 CISPLATIN + GEMCITABINE
220007813 220018936 null 77.5 null 2014-09-26 2014-09-26 AML16 DA 3+10 02 N 220033204 AML16 TRIAL
220007814 220018936 163 58.4 Curative (C) 2013-06-08 2013-06-10 AML16 DA 3+10 N N 220033204 AML16 TRIAL
220007815 220018936 1.69 82.6 Curative (C) null 2014-06-30 Idarubicin+Tretinoin Spanish Crse2 02 N 220033204 IDARUBICIN + TRETINOIN
220007816 220003100 1.5 59 Palliative (P) 2014-06-13 2014-06-13 Cisplatin + Gemcitabine (D 1 & 8) N null 220033217 CISPLATIN + GEMCITABINE
220007817 220003100 1.5 47.2 Curative (C) 2015-12-17 2015-12-18 AML18 PILOT TRIAL Y null 220033217 PILOT TRIAL
220007818 220003100 1.62 54.25 Curative (C) 2017-06-03 2017-06-03 AML18 PILOT TRIAL Y N 220033217 PILOT TRIAL
220007819 220003101 1.82 93 Disease modification (D) 2015-03-21 2015-03-25 AML18 PILOT TRIAL N N 220033222 PILOT TRIAL
220007820 220003101 1.78 99 null 2017-10-03 2017-10-03 AML16 DA 3+8 N N 220033222 AML16 TRIAL
220007821 220003102 1.79 null Disease modification (D) 2016-09-06 2016-09-07 AML 18 TRIAL Y N 220033224 AML18 TRIAL
220007823 220003104 null 100.5 null 2013-06-06 2013-06-09 GemCarbo Days 1+8 2 null 220033231 GEMCARBO
220007824 220003104 1.57 58.2 Curative (C) 2015-08-07 2015-08-07 AML 18 Pilot Trial N N 220033231 PILOT TRIAL
220007825 220003105 1.48 73 Palliative (P) 2014-05-21 2014-05-22 GemCarbo Days 1+8 N N 220033240 GEMCARBO
220007826 220003106 1.59 null null 2017-08-26 2017-08-29 AML 18 TRIAL N N 220033242 AML18 TRIAL
220007827 220003107 1.57 null Palliative (P) 2015-06-20 2015-06-20 Cisplatin + Gemcitabine (D 1 & 8) 02 N 220033243 CISPLATIN + GEMCITABINE
220007828 220003108 null 76.2 Neo-adjuvant (N) null 2015-09-19 Carboplatin + Paclitaxel (3 weekly) N null 220033245 CARBOPLATIN + PACLITAXEL
220007829 220003108 null 73.5 Palliative (P) 2015-03-27 2015-04-30 Carboplatin + Paclitaxel (weekly) 2 N 220033245 CARBOPLATIN + PACLITAXEL
220007830 220003109 1.86 null Curative (C) 2015-08-06 2015-08-06 AML 18 TRIAL Y N 220033250 AML18 TRIAL
220007831 220003110 1.73 82 Curative (C) 2013-04-17 2013-04-28 AML18 PILOT TRIAL N null 220033254 PILOT TRIAL
220007832 220003111 0 82.3 Curative (C) 2014-10-10 2014-10-10 AML16 Azacitidine Y N 220033256 AML16 TRIAL
220007833 220003111 1.77 119 Curative (C) 2014-05-17 2014-05-28 AML 18 TRIAL 1 N 220033256 AML18 TRIAL
220007834 220003112 1.5 null Curative (C) 2017-02-28 2017-02-28 AML16 Azacitidine N N 220033259 AML16 TRIAL
220007835 220011734 1.86 0 Curative (C) 2016-01-01 2016-01-06 AML16 Azacitidine N N 220033260 AML16 TRIAL
220007836 220003113 null 94.6 Disease modification (D) 2016-03-23 2016-03-24 AML 18 TRIAL 01 N 220033262 AML18 TRIAL
220007837 220003114 1.54 117.4 Palliative (P) 2014-05-19 2014-06-24 Carboplatin + Paclitaxel (3 weekly) 02 N 220033266 CARBOPLATIN + PACLITAXEL
220007838 220003115 0 87 Curative (C) null 2017-07-24 Idarubicin+Tretinoin Spanish Crse1 2 N 220033268 IDARUBICIN + TRETINOIN
220007839 220003116 null 47.5 Palliative (P) 2014-11-23 2014-12-12 Dasatinib null N 220033269 DASATINIB
220007840 220003117 1.78 78.1 Curative (C) 2017-11-30 2017-11-02 Carboplatin + Paclitaxel (3 weekly) 02 N 220033272 CARBOPLATIN + PACLITAXEL
220007843 220003119 1.71 61.5 Palliative (P) 2015-01-14 2015-01-20 Carboplatin + Etoposide iv&po null null 220033279 CARBOPLATIN + ETOPOSIDE
220007844 220003120 0 75.6 Palliative (P) 2017-04-13 2017-05-03 EOX 2 N 220033281 EOX
220007845 220003121 1.7 101 Neo-adjuvant (N) 2016-12-01 2016-12-15 ECX null null 220033283 ECX
220007846 220003121 null 63 Palliative (P) 2016-01-11 2016-01-13 Rituximab N N 220033283 RAVVA TRIAL
220007847 220003122 1.57 78.2 Palliative (P) 2014-02-27 2014-02-28 Carboplatin + Etoposide iv&po N N 220033286 CARBOPLATIN + ETOPOSIDE
220007848 220003122 null 99.5 Curative (C) 2013-08-22 2013-08-22 ADE 10+3+5 N null 220033286 ADE
220007849 220003122 1.58 68 Curative (C) 2016-02-22 2016-02-22 AML Int Guide ADE 10+3+5 (1) N N 220033286 ADE
220007850 220003122 1.53 99.2 Palliative (P) 2015-10-23 2015-10-25 Gemcitabine weekly N N 220033286 PEMBROLIZUMAB